Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (GF Jooste Hospital)

South African Medical Journal

Volumn 99, Issue 5, 2009, Pages 320-325

  Kevany, Sebastian ^a,b   Meintjes, Graeme ^a,c   Rebe, Kevin ^a,c   Maartens, Gary ^a   Cleary, Susan ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GF Jooste Hospital   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ANTIRETROVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; FEMALE; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT CARE; SOUTH AFRICA; TUBERCULOSIS; AMBULATORY CARE; COHORT ANALYSIS; ECONOMICS; HEALTH CARE QUALITY; HOSPITALIZATION; MIDDLE AGED; PATIENT REFERRAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY;

ADULT; AMBULATORY CARE; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HEALTH CARE COSTS; HIV INFECTIONS; HOSPITALIZATION; HOSPITALS, PUBLIC; HUMANS; MALE; MIDDLE AGED; PROGRAM EVALUATION; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SOUTH AFRICA; YOUNG ADULT;

EID: 67651210831     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Department of Health. National Antiretroviral Treatment Guidelines. Pretoria: Department of Health, 2004.
2. Forsythe S, Gilks C. Economic Issues and Antiretroviral Therapy in Developing Countries. Trans R Soc Trop Med Hyg 1999; 93(1): 1-3.
3. Casseb J, Fonseca LA, Veiga AP, et al. AIDS Incidence and mortality in a hospital-based cohort of HIV-1-seropositive patients receiving highly active antiretroviral therapy in Sao Paulo, Brazil. AIDS Patient Care STDS 2003; 17(9): 447-452.
4. Arens FJ, Maartens G. Treatment Costs for HIV/AIDS in a Managed Care Setting in South Africa. Presentation to the 38th Annual Congress of the South African Pharmacology Society, Bloemfontein, 24 - 27 October 2004.
5. Cleary S, Blecher M, Boulle A, et al. The costs of the National Strategic Plan on HIV and AIDS & STIs 2007-2011. http://www.tac.org.za/documents/NSPCostingFinal.doc (accessed 1 June 2007).
6. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18: 887-895.
7. Boulle A. Antiretroviral Therapy and Early Mortality in South Africa. Bull World Health Organ 2008; 86 (8).
8. Nattrass N, Leibbrant M, Seekings J, et al. Khayelitsha/Mitchell's Plain Survey 2000: Survey Report and Baseline Information. Cape Town: Centre for Social Science Research, University of Cape Town and the Population Studies Center, University of Michigan, 2003.
9. Drummond M, McGuire A, eds. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford: Oxford University Press, 2001.
10. Cleary S, McIntyre D, Boulle A. The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa: a primary data analysis. Cost-Effectiveness and Resource Allocation 2006; 4: 20.
11. National Health Laboratory Service. Laboratory Costs Estimates. Johannesburg: National Health Laboratory Service, 2004. http://www.nhls.ac.za (accessed 1 June 2005).
12. Community Health Services Organisation (2004) Community Health Services Organisation Drug Price Listings. Cape Town: Community Health Services Organisation, 2004.
13. Department of Health. Uniform Fee Payment Schedule. Pretoria: Department of Health, 2005.
14. Shepard S. Analysis of Hospital Costs: A Manual for Managers. Geneva: World Health Organization, 2000.
15. Creese A, Parker D. Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva: World Health Organization, 1994.
16. Haile B. Costs of Adult Inpatient Care for HIV Disease at GF Jooste Hospital. MPH thesis, University of Cape Town, 2000.
17. Beck EJ, Miners AH, Tolley K. The cost of HIV treatment and care: A global review. Pharmacoeconomics 2001; 19(1): 13-39.
18. Beck EJ, Santas XM, DeLay PR. Why and how to monitor the cost and evaluate the costeffectiveness of HIV services in countries. AIDS 2008; 22 suppl 1: S75-S85.
19. Walker D. Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: Is there an evidence base? Health Policy and Planning 2003; 18 (1): 4-17.
20. Cleary S, Boulle A, Castillo-Riquelme M, et al. The burden of HIV/ AIDS in the public health system. S Afr J Economics 2008; 76 suppl 1: S3-S14.
21. Guthrie T, Hickey A. Funding the Fight: Budgeting for HIV/AIDS in Developing Countries. Cape Town: IDASA, 2004.
22. Thomas LS, Manning A, Holmes CB, et al. Comparative costs of inpatient care for HIVinfected and uninfected children and adults in Soweto, South Africa. J AIDS 2007; 46(4): 410-415.